vs

Side-by-side financial comparison of Grove Collaborative Holdings, Inc. (GROV) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $42.4M, roughly 1.1× Grove Collaborative Holdings, Inc.). Grove Collaborative Holdings, Inc. runs the higher net margin — -3.7% vs -90.4%, a 86.7% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -14.3%). Grove Collaborative Holdings, Inc. produced more free cash flow last quarter ($-62.0K vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -11.0%).

Grove Collaborative is a benefit corporation headquartered in San Francisco, with an additional office in Portland, Maine. The company makes and sells its own environmentally friendly home and personal care products under its Grove Co. brand, as well as products from other companies.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

GROV vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.1× larger
PACB
$44.6M
$42.4M
GROV
Growing faster (revenue YoY)
PACB
PACB
+28.1% gap
PACB
13.8%
-14.3%
GROV
Higher net margin
GROV
GROV
86.7% more per $
GROV
-3.7%
-90.4%
PACB
More free cash flow
GROV
GROV
$19.9M more FCF
GROV
$-62.0K
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-11.0%
GROV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GROV
GROV
PACB
PACB
Revenue
$42.4M
$44.6M
Net Profit
$-1.6M
$-40.4M
Gross Margin
53.0%
37.1%
Operating Margin
-3.7%
-92.3%
Net Margin
-3.7%
-90.4%
Revenue YoY
-14.3%
13.8%
Net Profit YoY
87.5%
-1802.7%
EPS (diluted)
$-0.06
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GROV
GROV
PACB
PACB
Q4 25
$42.4M
$44.6M
Q3 25
$43.7M
$38.4M
Q2 25
$44.0M
$39.8M
Q1 25
$43.5M
$37.2M
Q4 24
$49.5M
$39.2M
Q3 24
$48.3M
$40.0M
Q2 24
$52.1M
$36.0M
Q1 24
$53.5M
$38.8M
Net Profit
GROV
GROV
PACB
PACB
Q4 25
$-1.6M
$-40.4M
Q3 25
$-3.0M
$-38.0M
Q2 25
$-3.6M
$-41.9M
Q1 25
$-3.5M
$-426.1M
Q4 24
$-12.6M
$2.4M
Q3 24
$-1.3M
$-60.7M
Q2 24
$-10.1M
$-173.3M
Q1 24
$-3.4M
$-78.2M
Gross Margin
GROV
GROV
PACB
PACB
Q4 25
53.0%
37.1%
Q3 25
53.3%
41.4%
Q2 25
55.4%
36.9%
Q1 25
53.0%
-3.7%
Q4 24
52.4%
25.6%
Q3 24
53.0%
25.0%
Q2 24
53.9%
16.5%
Q1 24
55.5%
29.1%
Operating Margin
GROV
GROV
PACB
PACB
Q4 25
-3.7%
-92.3%
Q3 25
-6.2%
-101.1%
Q2 25
-7.9%
-112.8%
Q1 25
-8.1%
-1154.5%
Q4 24
-16.8%
-390.1%
Q3 24
-14.0%
-160.3%
Q2 24
-13.3%
-488.3%
Q1 24
-1.0%
-209.6%
Net Margin
GROV
GROV
PACB
PACB
Q4 25
-3.7%
-90.4%
Q3 25
-6.8%
-98.9%
Q2 25
-8.2%
-105.4%
Q1 25
-8.1%
-1146.8%
Q4 24
-25.5%
6.0%
Q3 24
-2.8%
-151.9%
Q2 24
-19.3%
-481.3%
Q1 24
-6.3%
-201.4%
EPS (diluted)
GROV
GROV
PACB
PACB
Q4 25
$-0.06
$-0.11
Q3 25
$-0.08
$-0.13
Q2 25
$-0.10
$-0.14
Q1 25
$-0.10
$-1.44
Q4 24
$-0.34
$-0.44
Q3 24
$-0.04
$-0.22
Q2 24
$-0.28
$-0.64
Q1 24
$-0.10
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GROV
GROV
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$8.5M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-17.0M
$5.3M
Total Assets
$53.1M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GROV
GROV
PACB
PACB
Q4 25
$8.5M
$279.5M
Q3 25
$8.9M
$298.7M
Q2 25
$10.0M
$314.7M
Q1 25
$9.6M
$343.1M
Q4 24
$19.6M
$389.9M
Q3 24
$50.8M
$471.1M
Q2 24
$78.8M
$509.8M
Q1 24
$77.8M
$561.9M
Total Debt
GROV
GROV
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$32.2M
Q2 24
Q1 24
Stockholders' Equity
GROV
GROV
PACB
PACB
Q4 25
$-17.0M
$5.3M
Q3 25
$-16.1M
$36.1M
Q2 25
$-14.0M
$61.5M
Q1 25
$-11.6M
$91.6M
Q4 24
$-8.5M
$506.6M
Q3 24
$1.5M
$453.1M
Q2 24
$686.0K
$492.7M
Q1 24
$7.5M
$649.0M
Total Assets
GROV
GROV
PACB
PACB
Q4 25
$53.1M
$784.1M
Q3 25
$54.6M
$803.2M
Q2 25
$57.8M
$825.5M
Q1 25
$59.8M
$860.8M
Q4 24
$65.0M
$1.3B
Q3 24
$105.2M
$1.5B
Q2 24
$131.8M
$1.5B
Q1 24
$137.9M
$1.7B
Debt / Equity
GROV
GROV
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
21.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GROV
GROV
PACB
PACB
Operating Cash FlowLast quarter
$-29.0K
$-19.1M
Free Cash FlowOCF − Capex
$-62.0K
$-19.9M
FCF MarginFCF / Revenue
-0.1%
-44.6%
Capex IntensityCapex / Revenue
0.1%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.1M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GROV
GROV
PACB
PACB
Q4 25
$-29.0K
$-19.1M
Q3 25
$-1.0M
$-18.7M
Q2 25
$987.0K
$-29.4M
Q1 25
$-6.9M
$-44.1M
Q4 24
$270.0K
$-30.6M
Q3 24
$750.0K
$-45.5M
Q2 24
$1.6M
$-54.3M
Q1 24
$-12.4M
$-75.7M
Free Cash Flow
GROV
GROV
PACB
PACB
Q4 25
$-62.0K
$-19.9M
Q3 25
$-1.2M
$-18.8M
Q2 25
$556.0K
$-29.9M
Q1 25
$-7.4M
$-45.4M
Q4 24
$-95.0K
$-32.3M
Q3 24
$264.0K
$-46.3M
Q2 24
$1.2M
$-55.7M
Q1 24
$-12.9M
$-79.6M
FCF Margin
GROV
GROV
PACB
PACB
Q4 25
-0.1%
-44.6%
Q3 25
-2.7%
-48.9%
Q2 25
1.3%
-75.3%
Q1 25
-17.0%
-122.3%
Q4 24
-0.2%
-82.3%
Q3 24
0.5%
-115.7%
Q2 24
2.3%
-154.8%
Q1 24
-24.1%
-205.0%
Capex Intensity
GROV
GROV
PACB
PACB
Q4 25
0.1%
1.9%
Q3 25
0.4%
0.2%
Q2 25
1.0%
1.4%
Q1 25
1.2%
3.7%
Q4 24
0.7%
4.1%
Q3 24
1.0%
2.0%
Q2 24
0.7%
4.1%
Q1 24
1.0%
10.0%
Cash Conversion
GROV
GROV
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GROV
GROV

Third Party Products$23.4M55%
Grove Brands$19.0M45%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons